Zitai Sang

457 total citations
19 papers, 391 citations indexed

About

Zitai Sang is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Zitai Sang has authored 19 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Organic Chemistry and 4 papers in Infectious Diseases. Recurrent topics in Zitai Sang's work include Cancer therapeutics and mechanisms (6 papers), Tuberculosis Research and Epidemiology (3 papers) and Peptidase Inhibition and Analysis (3 papers). Zitai Sang is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Tuberculosis Research and Epidemiology (3 papers) and Peptidase Inhibition and Analysis (3 papers). Zitai Sang collaborates with scholars based in China and United States. Zitai Sang's co-authors include Tao Yang, Youfu Luo, Yang Yang, Pingxian Liu, Tianyu Zhang, Yuan Ju, Qi An, Wei Ang, Yong Deng and Xiaogang Li and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and Nanoscale.

In The Last Decade

Zitai Sang

19 papers receiving 387 citations

Peers

Countries citing papers authored by Zitai Sang

Since Specialization

Citations

This map shows the geographic impact of Zitai Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zitai Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zitai Sang more than expected).

Fields of papers citing papers by Zitai Sang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zitai Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zitai Sang. The network helps show where Zitai Sang may publish in the future.

Co-authorship network of co-authors of Zitai Sang

This figure shows the co-authorship network connecting the top 25 collaborators of Zitai Sang. A scholar is included among the top collaborators of Zitai Sang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zitai Sang. Zitai Sang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Discovery of Novel Peptidomimetic Boronate ClpP Inhibitors with Noncanonical Enzyme Mechanism as Potent Virulence Blockers in Vitro and in Vivo 2020 ·Journal of Medicinal Chemistry ·Yuan Ju, Lihui He, (unknown), Tao Yang, Ke Sun, (unknown), Yang Yang, Chengwei Li, Zitai Sang, Rui Bao, Youfu Luo	25
2	Discovery of napabucasin derivatives for the treatment of tuberculosis 2019 ·MedChemComm ·Chungen Li, (unknown), Zitai Sang, Yang Yang, Yamin Gao, Tao Yang, (unknown), Tianyu Zhang, Youfu Luo	7
3	Efficient discovery of novel antimicrobials through integration of synthesis and testing in crude ribosome extract 2019 ·Chemical Communications ·Zitai Sang, Yongping Lu, (unknown), Yuan Ju, Qi An, (unknown), Jianyou Shi, Jun He, Tao Yang, Youfu Luo	5
4	Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold 2018 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Yang Yang, Qi An, Zitai Sang, Tao Yang, Pingxian Liu, Tianyu Zhang, Yong Deng, Youfu Luo	42
5	Design and synthesis of novel pyrimidine derivatives as potent antitubercular agents 2018 ·European Journal of Medicinal Chemistry ·Pingxian Liu, Yang Yang, (unknown), Tao Yang, Zitai Sang, Xiaogang Li, Tianyu Zhang, Youfu Luo	62
6	Design, synthesis and biological evaluation of novel pyrrole derivatives as potential ClpP1P2 inhibitor against Mycobacterium tuberculosis 2018 ·Bioorganic Chemistry ·Pingxian Liu, Yang Yang, Yuan Ju, (unknown), Zitai Sang, Lijuan Chen, Tao Yang, Qi An, Tianyu Zhang, Youfu Luo	17
7	Discovery of hybrids of indolin-2-one and nitroimidazole as potent inhibitors against drug-resistant bacteria 2018 ·The Journal of Antibiotics ·(unknown), Yuan Ju, Yang Yang, Zitai Sang, Zhenling Wang, Gu He, Tao Yang, Youfu Luo	16
8	A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3) 2018 ·European Journal of Medicinal Chemistry ·Chungen Li, Caili Chen, Qi An, Tao Yang, Zitai Sang, Yang Yang, Yuan Ju, Aiping Tong, Youfu Luo	33
9	Design, synthesis, and biological evaluation of quinazoline derivatives as dual HDAC1 and HDAC6 inhibitors for the treatment of cancer 2018 ·Chemical Biology & Drug Design ·Jinying Chen, Zitai Sang, (unknown), Chao Yang, Linhong He	24
10	Discovery of 5-methyl-2-(4-((4-(methylsulfonyl)benzyl)oxy)phenyl)-4-(piperazin-1-yl)pyrimidine derivatives as novel GRP119 agonists for the treatment of diabetes and obesity 2017 ·Molecular Diversity ·Jinying Chen, Zitai Sang, Li Lu, Linhong He, Liang Ma	9
11	Improving the pharmacokinetics and tissue distribution of pyrinezolid by self-assembled polymeric micelles 2017 ·Colloids and Surfaces B Biointerfaces ·(unknown), Xiaoling Li, Zitai Sang, Mei Lan, Tao Yang, Zicheng Li, Liangxue Zhou, Yu Zheng, Gu He, Gang Guo, Zhenling Wang, Yong Deng, Youfu Luo	14
12	Inclusion complex of magnolol with hydroxypropyl-β-cyclodextrin: characterization, solubility, stability and cell viability 2016 ·Journal of Inclusion Phenomena and Macrocyclic Chemistry ·Neng Qiu, (unknown), Xuebing Li, Xiaotong Zhang, Zitai Sang, Tao Yang, (unknown), Junda Liu, (unknown), Lan Wang	14
13	Discovery of a Teraryl Oxazolidinone Compound (S)-N-((3-(3-Fluoro-4-(4-(pyridin-2-yl)-1H-pyrazol-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide Phosphate as a Novel Antimicrobial Agent with Enhanced Safety Profile and Efficacies 2015 ·Journal of Medicinal Chemistry ·Tao Yang, Gong Chen, Zitai Sang, Yuanyuan Liu, Xiaoyan Yang, Ying Chang, (unknown), Wei Ang, (unknown), Zhenling Wang, Guo‐Bo Li, Shengyong Yang, Jing-Ren Zhang, Yuquan Wei, Youfu Luo	31
14	The in vivo and in vitro phase I metabolism of FYL‐67, a novel oxazolidinone antibacterial drug, studied by LC‐MS/MS 2015 ·Drug Testing and Analysis ·Zitai Sang, (unknown), Tao Yang, Weiwei Ye, Xiaoyan Yang, Gong Chen, Zhenling Wang, Youfu Luo	1
15	Natural amino acid salt catalyzed aldol reactions of isatins with ketones: highly enantioselective construction of 3-alkyl-3-hydroxyindolin-2-ones 2015 ·Tetrahedron Asymmetry ·Chen Gong, Yuan Ju, Tao Yang, Zicheng Li, Wei Ang, Zitai Sang, Jie Liu, Youfu Luo	17
16	Synthesis and antibacterial activity evaluation of C-5 side chain modified analogues of FYL-66, a potential agent against methicillin-resistant Staphylococcus aureus 2015 ·MedChemComm ·Xiaoyan Yang, Zicheng Li, Zhenling Wang, Zitai Sang, (unknown), (unknown), Tao Yang, Yuanyuan Liu, Youfu Luo	4
17	Discovery of novel bis-oxazolidinone compounds as potential potent and selective antitubercular agents 2014 ·Bioorganic & Medicinal Chemistry Letters ·Wei Ang, Weiwei Ye, Zitai Sang, Yuanyuan Liu, Tao Yang, Yong Deng, Youfu Luo, Yuquan Wei	19
18	Biodegradable nanoassemblies of piperlongumine display enhanced anti-angiogenesis and anti-tumor activities 2014 ·Nanoscale ·Yuanyuan Liu, Ying Chang, Chao Yang, Zitai Sang, Tao Yang, Wei Ang, Weiwei Ye, Yuquan Wei, Changyang Gong, Youfu Luo	39
19	Exploratory Process Development and Kilogram-Scale Synthesis of a Novel Oxazolidinone Antibacterial Candidate 2014 ·Organic Process Research & Development ·Tao Yang, Jiaxiang Chen, (unknown), (unknown), (unknown), (unknown), Zitai Sang, Youfu Luo	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact